India hosts the BRICS Heads in Guwahati, chaired by the Narcotics Control Bureau, and anti-drug agencies from BRICS nations to address the rising concerns over drug trafficking and substance abuse globally
Granules India secures first-to-file status for their drug Lumryz, which belongs to the complex generic drug category and is a cure for narcolepsy, a neurological disorder that affects the brain's ability to regulate sleep
NITI Aayog steps up to taking the indian traditional healthcare into global attention, with further evidence-based research and development, Ayurveda is expected to be popularised globally for its efficiency in preventive healthcare solutions.
India has introduced a major regulatory change for Stem Cell and Gene Therapy, bringing these advanced treatments under a central licensing framework.
Glenmark shares came under pressure after the US FDA issued six observations following an inspection of the company's Goa plant.
Telangana welcomes corporates by setting the ground for business and development for pharmaceuticals, GCCs, research institutions, and startups, taking a shift from implementing subsidies to being prominent in business and innovation
Aurobindo Pharma's Lannett Acquisition has officially entered a new phase with the successful completion of its USD 250 million buyout of US-based Lannett Company.
The Union Ministry of Health and Family Welfare has announced a single platform for all medicine-related information, which creates a space that users can easily access for domestic generic medicines through the respective generic name and brand name
Aurobindo Pharma's API Plant Clears FDA Review With Minor Findings as the company received only two observations from the US Food and Drug Administration (USFDA) following an inspection of one of its API plant facilities.
The Imported Drug Shelf Life Rule could soon see a major change in India. The Central government has proposed scrapping the existing 60 percent residual shelf life requirement for imported medicines and replacing it with a simpler 12-month rule.